Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Akebia Therapeutics, Inc. (AKBA)

« Back to company index

AKBA Chatter Timeline

Stock Ticker for AKBA

Most Active Tweeters for AKBA

UserTweets
@Gambiste1 5
@AmericanBanking 4
@theBigCatalyst 4
@Tickeron 4
@portefeuillefun 2

Recent Tweets for AKBA

TickerReport @TickerReport
Akebia Therapeutics Inc $AKBA Receives Average Recommendation of “Hold” from Analysts https://t.co/hdkpUNDuRD
June 17th 2019, 6:06pm
tradnews_ @tradnews_
RT @AlertTrade: TREND REVERSAL UP ALERT: $AKBA Akebia Therapeutics, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room
June 17th 2019, 12:06pm
AlertTrade @AlertTrade
TREND REVERSAL UP ALERT: $AKBA Akebia Therapeutics, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room
June 17th 2019, 12:06pm
theBigCatalyst @theBigCatalyst
And there's another winner I posted about! $AKBA 6% alresdy
June 17th 2019, 10:06am
MarketChmln @MarketChmln
$AKBA $AKBA upcoming event June 19: Raymond James Life Sciences and MedTech Conference. Options expiring on June 21… https://t.co/OGIX8Of0zb
June 16th 2019, 4:06pm
Gambiste1 @Gambiste1
RT @theBigCatalyst: $AKBA and here is the 1hr charts. It is literally right down to the very last penny! If it holds this psuedo-support,…
June 15th 2019, 6:06am
Gambiste1 @Gambiste1
RT @theBigCatalyst: $AKBA stock looks very ready to reverse -- I'm seeing serious reversal indicators throughout multiple timeframes. My da…
June 15th 2019, 6:06am
Gambiste1 @Gambiste1
RT @theBigCatalyst: $AKBA oh and did I say that 5-star analyst Christopher Raymond of Piper Jaffray has a $22.00 price target on this?? Tha…
June 15th 2019, 5:06am
theBigCatalyst @theBigCatalyst
$AKBA oh and did I say that 5-star analyst Christopher Raymond of Piper Jaffray has a $22.00 price target on this??… https://t.co/dVTpEqPeR7
June 15th 2019, 4:06am
theBigCatalyst @theBigCatalyst
$AKBA and here is the 1hr charts. It is literally right down to the very last penny! If it holds this psuedo-suppo… https://t.co/spkkEmbvA0
June 15th 2019, 4:06am
theBigCatalyst @theBigCatalyst
$AKBA stock looks very ready to reverse -- I'm seeing serious reversal indicators throughout multiple timeframes. M… https://t.co/R7m6CmxkPG
June 15th 2019, 4:06am
ThisLincolnian @ThisLincolnian
Akebia Therapeutics $AKBA Rating Lowered to Sell at ValuEngine https://t.co/If31Z2K7a1
June 14th 2019, 9:06am
Gambiste1 @Gambiste1
RT @USMC_1982: $AKBA Don't think this has been found, but I will start adding slowly tomorrow/watching. This PR was out on 6/11 and chart…
June 13th 2019, 10:06pm
USMC_1982 @USMC_1982
$AKBA Don't think this has been found, but I will start adding slowly tomorrow/watching. This PR was out on 6/11 a… https://t.co/t6akB4i11M
June 13th 2019, 9:06pm
TranscriptDaily @TranscriptDaily
Analysts Anticipate Akebia Therapeutics Inc $AKBA Will Post Earnings of -$0.35 Per Share https://t.co/hOLfgWH7Zf
June 13th 2019, 8:06pm
registrarjourn @registrarjourn
Analysts Expect Akebia Therapeutics Inc $AKBA Will Announce Quarterly Sales of $84.85 Million https://t.co/s5536LJU7E
June 13th 2019, 8:06pm
EnterpriseLeade @EnterpriseLeade
Analysts Expect Akebia Therapeutics Inc $AKBA Will Announce Quarterly Sales of $84.85 Million https://t.co/5jkVV1VVi3
June 13th 2019, 8:06pm
AmericanBanking @AmericanBanking
Analysts’ Upgrades for June, 13th $AKBA, ALXN, ANDE, ARCB, CENX, CHKP, CONN, ECHO, FTNT, HCKT https://t.co/xwIl51KZ1m #stocks
June 13th 2019, 2:06pm
TickerReport @TickerReport
Analysts’ Upgrades for June, 13th $AKBA, ALXN, ANDE, ARCB, CENX, CHKP, CONN, ECHO, FTNT, HCKT https://t.co/6rnNjA3sWz
June 13th 2019, 1:06pm
ThisLincolnian @ThisLincolnian
BidaskClub Upgrades Akebia Therapeutics $AKBA to “Sell” https://t.co/xk6qtHVItY
June 13th 2019, 1:06pm
SwingTradeBot @SwingTradeBot
New 52 Week Low today: $EDNT $AKBA ... https://t.co/0EM4q8YtyQ
June 13th 2019, 1:06pm
TheMarketsDaily @TheMarketsDaily
Analysts Set Akebia Therapeutics Inc $AKBA Price Target at $14.50 https://t.co/sYAHVj6XHu
June 13th 2019, 10:06am
WatchlistN @WatchlistN
Akebia Therapeutics $AKBA Downgraded by ValuEngine to “Sell” https://t.co/w34W5LkpRe
June 12th 2019, 2:06am
filingsdb @filingsdb
New Form 8-K filed by Akebia Therapeutics, Inc. $AKBA - https://t.co/rWiUQy3V94
June 11th 2019, 4:06pm
ConsumerFeed @ConsumerFeed
Akebia Therapeutics Inc $AKBA Expected to Announce Quarterly Sales of $84.85 Million https://t.co/yvfZi39zKK
June 11th 2019, 12:06pm
InsiderAlertsIA @InsiderAlertsIA
$AKBA: New Insider Filing on Insider CYNTHIA SMITH: https://t.co/YKeMEureNs
June 10th 2019, 4:06pm
AmericanBanking @AmericanBanking
Akebia Therapeutics Inc $AKBA Given Average Recommendation of “Hold” by Brokerages https://t.co/eNLz47TMTp #stocks
June 10th 2019, 8:06am
ZolmaxNews @ZolmaxNews
-$0.35 EPS Expected for Akebia Therapeutics Inc $AKBA This Quarter https://t.co/HVCPrgvoNN
June 9th 2019, 8:06am
Tickeron @Tickeron
$AKBA Akebia Therapeutics (AKBA, $4.23) hits all-time low after falling -2.76% today. Expect a Downtrend reversal https://t.co/tr2QHWt9XD
June 8th 2019, 4:06am
AmericanBanking @AmericanBanking
Akebia Therapeutics Inc $AKBA Expected to Post Quarterly Sales of $84.85 Million https://t.co/9tvAYjo3i2 #stocks
June 8th 2019, 3:06am
dispatchtribune @dispatchtribune
Akebia Therapeutics Inc $AKBA Expected to Announce Quarterly Sales of $84.85 Million https://t.co/VwnlRyPWEl
June 8th 2019, 3:06am
portefeuillefun @portefeuillefun
Bought 2k $AKBA at $4.185, now 7k #vssporte shares.
June 7th 2019, 12:06pm
Tickeron @Tickeron
$AKBA Akebia Therapeutics (AKBA, $4.35) hits all-time low after falling -7.64% today. Expect a Downtrend reversal https://t.co/4aLgTtYXk4
June 7th 2019, 4:06am
Gambiste1 @Gambiste1
RT @portefeuillefun: Bought 2k $AKBA at $4.21, now 5k #vssporte shares.
June 6th 2019, 10:06am
AmericanBanking @AmericanBanking
Brokerages Expect Akebia Therapeutics Inc $AKBA Will Post Earnings of -$0.35 Per Share https://t.co/VhWETtuKtS #stocks
June 6th 2019, 10:06am
portefeuillefun @portefeuillefun
Bought 2k $AKBA at $4.21, now 5k #vssporte shares.
June 6th 2019, 9:06am
SeekingAlpha @SeekingAlpha
$AKBA - Akebia Therapeutics (AKBA) Presents At 2019 Jefferies Global Healthcare Conference - Slideshow https://t.co/Ky0XdX4885
June 5th 2019, 12:06pm
Tickeron @Tickeron
$AKBA Akebia Therapeutics (AKBA, $4.49) was the month's biggest loser, shedding -28% https://t.co/CslW84jfsT
June 5th 2019, 3:06am
Tickeron @Tickeron
$AKBA Akebia Therapeutics (AKBA, $4.49) was this quarter's top loser, falling -39% https://t.co/o8ZkysrA1K
June 4th 2019, 5:06pm
filingsdb @filingsdb
New Form 8-K filed by Akebia Therapeutics, Inc. $AKBA - https://t.co/IURkSgZ5xD
June 4th 2019, 7:06am
confcalltran @confcalltran
Akebia Therapeutics, Inc. insider just picked up 25,000 shares https://t.co/5E8paJ7k5M $AKBA
June 3rd 2019, 4:06pm
InsiderAlertsIA @InsiderAlertsIA
$AKBA: New Insider Filing on CCO DELL FAULKINGHAM: https://t.co/ZHJXD4ab8N
June 3rd 2019, 4:06pm
Tickeron @Tickeron
$AKBA Akebia Therapeutics (AKBA, $4.45) was the month's biggest loser, shedding -26% https://t.co/i9MQSf85N5
June 2nd 2019, 4:06am
Tickeron @Tickeron
$AKBA Akebia Therapeutics (AKBA, $4.45) hits all-time low after falling -7.68% today https://t.co/5w4AbyPfCE
June 1st 2019, 6:06pm
Tickeron @Tickeron
$AKBA Akebia Therapeutics (AKBA, $4.45) was this quarter's top loser, falling -42% https://t.co/zNtMQNTkUD
June 1st 2019, 1:06pm
gcassidy718 @gcassidy718
$AKBA over reaction will be back up -7.68 % https://t.co/WkIGTTkD3C
June 1st 2019, 2:06am
stocknewstimes @stocknewstimes
Akebia Therapeutics $AKBA Hits New 52-Week Low at $5.03 https://t.co/QfCbg1DFVn
May 31st 2019, 2:05am
SleekMoneycom @SleekMoneycom
Akebia Therapeutics $AKBA Hits New 52-Week Low at $5.03 https://t.co/ZPdc0gVCcf #investing
May 31st 2019, 2:05am
gcassidy718 @gcassidy718
$AKBA you'll be buying back at $4.37 https://t.co/WkIGTTkD3C
May 30th 2019, 5:05pm
Analyst_Ratingz @Analyst_Ratingz
$AKBA has 7 buy rating(s), 0 sell rating(s) and 3 hold rating(s) https://t.co/56r8kvuS0g
May 29th 2019, 10:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.